Funding for this research was provided by:
National Center for Complementary and Integrative Health (R01 AT008404)
National Institute on Drug Abuse (R01 DA030150)
U.S. Department of Veterans Affairs (14-232)
Received: 27 October 2020
Accepted: 17 May 2021
First Online: 24 May 2021
: Brandeis University’s Committee for Protection of Human Subjects, the Human Research Protection Program (IRB # 14153) at the Office of the Assistant Secretary of Defense for Health Affairs/Defense Health Agency (DHQ-15-2039), and the Stanford University and VA Palo Alto Health Care System (IRB #53744) institutional review boards conducted the human subjects review and approved the study. The Defense Health Agency’s Privacy and Civil Liberties Office executed the data use agreement. This study was deemed exempt under category #4 due to our use of secondary existing data. Therefore, no consent was required from subjects.
: Not applicable.
: The authors declare that they have no competing interests.